Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.

Galli A, Zatti C, Lupini A, Caminiti SP, Rizzardi A, Lucchini S, Bertagna F, Paghera B, Outeiro TF, Perani D, Padovani A, Pilotto A

Open source

DOI: 10.1007/s00259-026-08011-0
Published: 2026 Sep
Container: European journal of nuclear medicine and molecular imaging
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00259-026-08011-0,
  title = {Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.},
  author = {Galli A and Zatti C and Lupini A and Caminiti SP and Rizzardi A and Lucchini S and Bertagna F and Paghera B and Outeiro TF and Perani D and Padovani A and Pilotto A},
  year = {2026},
  journal = {European journal of nuclear medicine and molecular imaging},
  doi = {10.1007/s00259-026-08011-0},
  url = {https://doi.org/10.1007/s00259-026-08011-0}
}

RIS

TY  - JOUR
TI  - Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.
AU  - Galli A
AU  - Zatti C
AU  - Lupini A
AU  - Caminiti SP
AU  - Rizzardi A
AU  - Lucchini S
AU  - Bertagna F
AU  - Paghera B
AU  - Outeiro TF
AU  - Perani D
AU  - Padovani A
AU  - Pilotto A
PY  - 2026
JO  - European journal of nuclear medicine and molecular imaging
DO  - 10.1007/s00259-026-08011-0
UR  - https://doi.org/10.1007/s00259-026-08011-0
ER  -

APA

A, G., C, Z., A, L., SP, C., A, R., S, L., F, B., B, P., TF, O., D, P., A, P., & A, P. (2026). Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-08011-0

Source records

pubmed · retrieved 2026-09-26T20:48:21.243Z